The North American Menopause Society (NAMS) is committed to ensuring balance, independence, and objectivity in all its educational activities. All those involved in the development of a continuing medical education (CME) activity are required to disclose financial relationships they or their spouse/partner have had during the last 12 months with a commercial interest whose products or services are discussed in the CME activity content, or with any commercial supporters of the activity, over which they have control.
For the Editorial Board, Dr. Bachmann reports: Research support: Berlex, Duramed, Johnson & Johnson, Pfizer, Roche, Wyeth; Speaker: Johnson & Johnson, Wyeth. Dr. Johnston reports: Advisory board: Paladin Labs Canada; Speaker: Paladin Labs Canada, Wyeth Canada. Dr. Kessel reports: Research support: Procter & Gamble, Wyeth; Speaker: Berlex, Merck, Procter & Gamble, Wyeth. Dr. Knobf reports: No significant financial relationships. Dr. Stewart reports: No significant financial relationships.
The NAMS Board of Trustees reports the following list of all financial relationships, not just those related to this CME activity: Dr. Clarkson reports: Member: Council on Hormone Education; Speaker: Wyeth. Dr. Freedman reports: Consultant: Alexza, Duramed, GlaxoSmithKline, Novartis, Organon, Pfizer, Vela, Wyeth; Research Support: GlaxoSmithKline, National Institutes of Health, Organon. Dr. Gallagher reports: Consultant, Research support: Organon, Pfizer, Wyeth. Dr. Goldstein reports: Advisory board: Eli Lilly, GlaxoSmithKline, Merck, Pfizer, Procter & Gamble. Dr. Gorodeski reports: Director, Medical Advisory Board: CytoCore. Dr. Henderson reports: Consultant: Council on Hormone Education, Wyeth. Dr. Kagan reports: Advisory board: Merck; Consultant: Merck, Roche/GlaxoSmithKline; Research support: Amgen, Aventis, Eli Lilly, Novartis, Procter & Gamble, Roche/GlaxoSmithKline, Wyeth; Speaker: Merck, Roche/GlaxoSmithKline. Dr. Pinkerton reports: Consultant: Boehringer Ingelheim, Duramed, Merck, Council on Hormone Education; Member: National Women's Health Resource Center; Research support: Solvay, Wyeth; Speaker: Merck. Dr. Reame reports: Consultant: Cypress Bioscience, Procter & Gamble; Research support: Novo Nordisk, Procter & Gamble. Dr. Rothert reports: No significant financial relationships. Dr. Schiff reports: Advisory board: Pause, the consumer magazine of the American College of Obstetricians and Gynecologists; Editor-in-chief: Menopause, the official journal of The North American Menopause Society. Dr. Speroff reports: Consultant: Warner-Chilcott; Research support: Barr, Berlex, Organon, Wyeth. Dr. Stuenkel reports: No significant financial relationships. Dr. Utian reports: Advisory board: Consultant: Barr/Duramed, Berlex, Depomed, Endoceutics, GlaxoSmithKline, Johnson & Johnson, Merck, Novartis, Organon, Pfizer, Roche/GlaxoSmithKline; Research support: Amylin, Barr, Berlex, Bristol Myers Squibb, Duramed, Eli Lilly, Forest, Galen, GlaxoSmithKline, Johnson & Johnson, Neurocrine, Novartis, Novo Nordisk, Organon, Pfizer, Pharmacia, Procter & Gamble, Roche, Sepracor, Solvay, 3M, Wyeth, Yamanouchi
For additional contributors, Ms. Boggs, Dr. Graham, and Ms. Wisch all report no significant financial relationships.